Scholars Central

Conference abstractPublished 24 Oct 2016

Low-dosed lyophilised plant tissue bearing VLPs of HBV small surface antigen as an oral booster vaccine against hepatitis B

Authors: Tomasz Pniewski

Polish Academy of Sciences, Poland

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

The continued HBV high prevalence coupled with deficiencies in vaccination programmes stimulate research on a new type of vaccines. Potential orally administered plant-based vaccine is highly attractive regarding efficacy, cost-effectiveness and availability of mass hepatitis B prevention. Freeze-dried oral formulations facilitate elimination of complex purification steps, size reduction and better stability during storage, as well as ensure controlled administration regime in minimised medical facilities. The aim of presented study was to develop a lyophilisation protocol facilitating successful processing of lettuce leaf tissue containing S-HBsAg formed into VLPs (Virus-Like Particles). Several drying profiles and excipients as well as effects of freezing rate and post-process residual moisture were analysed. The profile of 20ºC for 20 h for primary and 22ºC for 2 h for secondary drying as well as sucrose proved the most efficient stabilisation of S-HBsAg during freeze-drying. The process was highly reproducible (86 - 97%), and provided a product with VLP content up to 200 µg/g DW. Atmosphere of nitrogen proved to preserve S-HBsAg VLPs for minimum one year at temperatures up to 37°C. Animal trials confirmed immunogenicity of processed tissue powder with S-HBsAg, used as an oral booster vaccine. Low-dosed (5 -200 ng) preparation elicited anti-HBs response at level of commercial injection vaccine (around 1000 mIU/ml), together with growth population of specific B and T lymphocytes and only slightly increased population of Tregs. As a result, a plant-derived semi-product with good long-term stability and immunogenicity of S-HBsAg was obtained for the definite formulation of oral booster vaccine against HBV.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • SubjectDentistry & Oral Health
  • SubjectGastroenterology & Hepatology
  • SubjectInfectious Diseases
  • BylineArticles whose byline prints “Tomasz Pniewski”